HK1183020A1 - 鈉-葡萄糖協同轉運蛋白 的抑制劑及其用法 - Google Patents

鈉-葡萄糖協同轉運蛋白 的抑制劑及其用法

Info

Publication number
HK1183020A1
HK1183020A1 HK13110285.8A HK13110285A HK1183020A1 HK 1183020 A1 HK1183020 A1 HK 1183020A1 HK 13110285 A HK13110285 A HK 13110285A HK 1183020 A1 HK1183020 A1 HK 1183020A1
Authority
HK
Hong Kong
Prior art keywords
transporter
inhibitors
methods
sodium glucose
glucose
Prior art date
Application number
HK13110285.8A
Other languages
English (en)
Inventor
C Goodwin Nicole
A Harrison Bryce
D Kimball Spencer
Mabon Ross
B Rawlins David
Original Assignee
Lexicon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lexicon Pharmaceuticals Inc filed Critical Lexicon Pharmaceuticals Inc
Publication of HK1183020A1 publication Critical patent/HK1183020A1/zh

Links

HK13110285.8A 2007-07-10 2013-09-04 鈉-葡萄糖協同轉運蛋白 的抑制劑及其用法 HK1183020A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94878007P 2007-07-10 2007-07-10

Publications (1)

Publication Number Publication Date
HK1183020A1 true HK1183020A1 (zh) 2013-12-13

Family

ID=40245429

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09102667.9A HK1124863A1 (en) 2007-07-10 2009-03-19 Inhibitors of sodium glucose co-transporter 2 and methods of their use
HK13110285.8A HK1183020A1 (zh) 2007-07-10 2013-09-04 鈉-葡萄糖協同轉運蛋白 的抑制劑及其用法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK09102667.9A HK1124863A1 (en) 2007-07-10 2009-03-19 Inhibitors of sodium glucose co-transporter 2 and methods of their use

Country Status (2)

Country Link
CN (2) CN101343296B (zh)
HK (2) HK1124863A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102453026A (zh) * 2010-10-27 2012-05-16 上海艾力斯医药科技有限公司 C-芳基葡糖苷衍生物、制备方法及其应用
JP6727419B2 (ja) * 2016-05-25 2020-07-22 クリスタル ファーマシューティカル（スーチョウ）カンパニー，リミテッド ナトリウム−グルコース共輸送体阻害薬の新規な結晶形及びその製造方法並びに用途
CN110092768A (zh) * 2018-04-23 2019-08-06 中国科学院成都生物研究所 包含钠-葡萄糖协同转运蛋白1抑制剂的组合物及使用方法
CN108610385A (zh) * 2018-04-23 2018-10-02 中国科学院成都生物研究所 一种钠-葡萄糖协同转运蛋白1抑制剂的药物用途
CN110117300A (zh) * 2018-04-23 2019-08-13 中国科学院成都生物研究所 包含钠-葡萄糖协同转运蛋白1抑制剂的药物用途
CN110818722B (zh) * 2018-08-14 2022-12-02 苏州鹏旭医药科技有限公司 三种化合物及其制备方法和在合成索格列净中的用途
CN109456370A (zh) * 2018-12-24 2019-03-12 重庆理工大学 一种钠-葡萄糖协同转运蛋白2抑制剂及其应用
KR102471055B1 (ko) * 2019-07-26 2022-11-28 메드샤인 디스커버리 아이엔씨. Sglt2/dpp4 억제제 및 이의 용도
CN113893256A (zh) * 2020-07-06 2022-01-07 诺未科技（北京）有限公司 化合物或其可药用盐、二聚体或三聚体在制备治疗癌症的药物中的应用
CN117599188A (zh) * 2020-07-06 2024-02-27 诺未科技（北京）有限公司 组合物及其在制备治疗癌症的药物中的应用
EP4249479A1 (en) * 2020-11-19 2023-09-27 Beijing Increase Innovative Drug Co., Ltd. Glucoside derivative, and preparation method therefor and application thereof
WO2022160737A1 (zh) * 2021-01-26 2022-08-04 东宝紫星(杭州)生物医药有限公司 四氢吡喃环类化合物的晶型及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12000002657B1 (en) * 1999-10-12 2006-02-21 Bristol Myers Squibb Co C-aryl glucoside SGLT2 inhibitors
ATE318272T1 (de) * 2001-04-11 2006-03-15 Bristol Myers Squibb Co Aminosäurekomplexe von c-arylglycosiden zur behandlung von diabetes und verfahren
CN101260130A (zh) * 2003-01-03 2008-09-10 布里斯托尔-迈尔斯斯奎布公司 制备c-芳基葡糖苷sglt2抑制剂的方法
MXPA05009356A (es) * 2003-03-14 2005-12-05 Astellas Pharma Inc Derivados de c-glicosido y sales de los mismos.
DE102004012676A1 (de) * 2004-03-16 2005-10-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Glucopyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
WO2006018150A1 (de) * 2004-08-11 2006-02-23 Boehringer Ingelheim International Gmbh D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
DE102004039096A1 (de) * 2004-08-11 2006-02-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg D-Xylopyranosyl-phenyl-substituierte Cyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE602006009772D1 (de) * 2005-02-23 2009-11-26 Boehringer Ingelheim Int Glucopyranosylsubstituierte ((hetero)arylethynyl-benzyl)-benzenderivative und deren verwendung als inhibitoren des natriumabhängigen glucose-cotransporters typ 2 (sglt2)

Also Published As

Publication number Publication date
CN103254119A (zh) 2013-08-21
CN101343296B (zh) 2013-04-10
CN101343296A (zh) 2009-01-14
CN103254119B (zh) 2016-07-06
HK1124863A1 (en) 2009-07-24

Similar Documents

Publication Publication Date Title
HUS1900038I1 (hu) Nátrium-glükóz kotranszporter-2 inhibitorai és alkalmazási eljárásaik
HK1183020A1 (zh) 鈉-葡萄糖協同轉運蛋白 的抑制劑及其用法
ZA201000219B (en) Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
HK1254895A1 (zh) 苄基苯衍生物及使用方法
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
EP1987068A4 (en) MODIFICATION OF OLIGOSACCHARIDES AND MARKING OF PROTEINS
IL232786A0 (en) Inhibitors of e1 enzyme activators
EP2019679A4 (en) GLUCOSE TRANSPORT AND APPLICATION METHOD
IL200576A0 (en) Inhibitors of rtp801 and their uses
IL205464A0 (en) Keratin derivatives and methods of making same
EP2170393A4 (en) ANTITROMOMBOTIC AGENTS AND METHOD OF USE THEREOF
ME02012B (me) INHIBITORI El AKTIVIRAJUĆIH ENZIMA
EP2188295A4 (en) PYRIDINE DERIVATIVES AND METHODS OF USE
PT2097457T (pt) Derivados de polissacarídeos ácidos
GB2441843B (en) Methods of testing in boreholes
EP2232263A4 (en) METHOD FOR DETERMINING THE EXCRETION OF SODIUM AND OTHER ANALYTES
GB2445651B (en) Well treatment products and methods of using them
IL200087A0 (en) Novel crystal of piperacillin sodium
EP1845984A4 (en) METHYLPHENIDATE DERIVATIVES AND THEIR USES
IL208809A (en) Oligosaccharides containing disaccharide units and methods for preparing them
IL192552A0 (en) Dnt-succinate and methods of preparation thereof
AU2006903156A0 (en) Method of hyaluronidase inhibition in vivo
PL379904A1 (pl) Kompozycja farmaceutyczna zawierająca topiramat lub jego farmaceutycznie dopuszczalną sól oraz sposób jej wytwarzania
PL386251A1 (pl) Nowe S-podstawione pochodne 2-tio-6-metylo-5-morfolinometylouracylu oraz sposób ich otrzymywania
TH110855B (th) การผลิตและการใช้โซเดียมไดฟอร์เมท